Latest News
-
From the Journals
Type 2 diabetes linked to increased risk for Parkinson’s
Both observational and genetic data have provided “convincing evidence” that T2D predisposes people to an increased risk for Parkinson’s disease...
-
From the Journals
Encephalopathy common, often lethal in hospitalized patients with COVID-19
Toxic metabolic encephalopathy was associated with a 24% higher risk of in-hospital death.
-
Feature
COVID-19 ‘long-haul’ symptoms overlap with ME/CFS
Long-term symptoms following acute COVID-19 illness were predictable based on prior experience with postviral fatigue syndromes including myalgic...
-
From the Journals
Simple blood test plus AI may flag early-stage Alzheimer’s disease
Deep Learning’s assessment of intragenic cytosine-phosphate-guanines (CpGs) had sensitivity and specificity rates of 97%.
-
Feature
Age-related cognitive decline not inevitable?
‘Cognitive decline is not inevitable,’ says an author of a new paper.
Conference Coverage
-
Conference Coverage
Can supplementary estrogen relieve MS symptoms in menopausal women?
Research suggests lowered hormone levels may worsen the disease.
-
Conference Coverage
Meta-analysis supports late thrombectomy in selected stroke patients
For every 100 patients treated with thrombectomy, 33 will have less disability, and 27 will achieve an independent level of functioning.
-
Conference Coverage
Is there a need for tPA before thrombectomy in patients with stroke?
The MR CLEAN NO IV trial failed to show superiority or noninferiority of direct endovascular treatment over intravenous tPA followed by...
News
-
News
What will neurology look like post pandemic?
Neurologists expect telemedicine – and post–COVID-19 sequelae – to stick around.
-
From the Journals
‘Beyond a reasonable doubt’: COVID-19 brain health fallout is real, severe
Hitting a Nerve
-
Hitting a Nerve
It’s time to retire the president question
A simple, time-honored, cognitive assessment question has become so polarizing that it is clinically worthless.
Literature Review
-
Literature Review
Green light puts the stop on migraine
Small study signals possible noninvasive approach.
-
Literature Review
Can exercise prevent cognitive decline in patients with early Parkinson’s disease?
Higher physical activity was related to slower APOE epsilon4-associated cognitive decline in patients with early Parkinson’s disease.
-
Literature Review
Ubrogepant safety and efficacy not affected by triptan therapy
The CGRP receptor antagonist shows promise, but hurdles set up by insurance companies limit its potential.